You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
27 July 2011
Raptor Pharmaceutical veranstaltet am Dienstag, den 26. Juli 2011 um 12 Uhr mittags EST Telefonkonferenz und Webcast zur Erörterung der Ergebnisse der klinischen Phase-III-Studie
26 July 2011
Raptor Pharmaceutical erreicht primären Endpunkt in seiner klinischen Phase-III-Studie zur Untersuchung von DR Cysteamin für nephropathische Cystinose
Raptor Pharmaceutical to Host Conference Call and Webcast to Discuss Phase 3 Clinical Trial Results on Tuesday, July 26, 2011 at Noon EDT
25 July 2011
Raptor Pharmaceutical Meets Primary Endpoint in Its Phase 3 Clinical Trial of DR Cysteamine for Nephropathic Cystinosis